With the rise of biologics, cold chain has become ever more important in pharmaceuticals. Grey market diversion is also a perennial issue. Here we discuss how a supply chain network solution can address both of these and we calculate the value that can be achieved.
Content Types
These are not topical or industry-specific categories, but rather types of content.
Brief – September 2024
Tuesday, September 10, 2024 – Published once each month. 2024 – World at Crossroads—Part Three: Elections The
2024: The World at Crossroads—Part Three
Indonesia—A New President, with a Troubling Past, Has Been Elected What happens in Indonesia has a significant
Quantifying the Value of Blockchain-Based Supply Chain Networks—Part Five
Pharmaceutical manufacturers can realize value by carefully and methodically reducing inventory, reducing the amount of drugs that expire, and reducing counterfeits in their supply chain, all by using a supply chain network solution. Here we describe the mechanisms and estimate the value of those improvements.
2024: The World at Crossroads—Part Two
Countries with over half the world’s population go to the polls this year. While none of these elections represent absolute good vs. evil, the outcomes will still make a big difference. In this global tug-of-war of ideas and institutions between democracy and autocracy, much is at stake for all of humanity, including peoples’ rights and liberties, the rules-based global order, world peace, and global prosperity.
2024: The World at Crossroads—Part One
Vital decisions in 2024 will affect all of humanity in areas such as democracy vs. autocracy, the future of AI, and dealing with disinformation. In this first article in the series, we focus on AI, which is poised to provide enormous benefits for mankind. At the same time, it presents considerable known issues right now; and speculative very-high-consequence risks in the future. Here we discuss why 2024 will be a pivotal year, setting the direction for how mankind addresses those near-term issues and longer-term risks, with implications for decades to come.
The Brief – January 2024
Thursday, January 4, 2024 – Published once each month. 2024: The World at Crossroads—Part One Foundational Decisions
Maritime Risk Remains High for Global Supply Chains Heading into 2024
As we begin 2024, the global economy faces heightened maritime risk vis-à-vis climate and geopolitical crises in the Panama Canal Zone, Red Sea, and Baltic Sea, on top of persistent maritime risks in the Middle East, East Asia, and Arctic Circle. Supply chain procurement leaders need to implement strategies and best practices to improvise, adapt, and overcome disruptions to global supply chains and shipping capacity in order to drive resilience through the global economy in 2024.
Achieving Transparency, Risk Reduction, and Impact with ESG Investing—Part Two
ESG investment claims to leverage financial markets in service of society and to reduce company risk. However, considerable doubts have been expressed about how effective ESG indices and investment actually are in driving meaningful changes. How can investors make informed investment choices to further their lofty goals? Data and reporting frameworks are the mechanisms to link ESG action to impact. Addressing inaccuracies and greenwashing in data and reporting can deliver the substantial potential value to financial risk and social value of ESG investment.
Quantifying the Value of Blockchain-Based Supply Chain Networks—Part Three
We propose and specify a hypothetical multi-enterprise supply chain application network with functionality for track and trace/recall, cold chain, inventory management, patient adherence, and identity management. Then we estimate the potential value of using such a network for an archetypal pharmaceutical manufacturer.
The Brief – November 2023
Wednesday, November 29, 2023 – Published once each month. Regulations’ Impact on ESG and Supply Chain Risk